Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5282-5293

  Litjens, Nicolle H R ^a   Boer, Karin ^a   Zuijderwijk, Joke M ^a   Klepper, Mariska ^a   Peeters, Annemiek M A ^a   Prens, Errol P ^a   Verschoor, Wenda ^a   Kraaijeveld, Rens ^a   Ozgur, Zeliha ^a   Van Den Hout Van Vroonhoven, Mirjam C ^a   Van IJcken, Wilfred F J ^a   Baan, Carla C ^a   Betjes, Michiel G H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CELL MARKER; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; PROTEIN HELIOS; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD4 ANTIGEN; CD86 PROTEIN, HUMAN; CTLA4 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HLA DR ANTIGEN; IKAROS TRANSCRIPTION FACTOR; IKZF2 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL15 PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 7 RECEPTOR ALPHA;

ARTICLE; CELL EXPANSION; CELL FRACTIONATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMETHYLATION; DENDRITIC CELL; FEMALE; FOXP3 GENE; HUMAN; HUMAN ALLOGENEIC MATURE MONOCYTE DERIVED DENDRITIC CELL; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MALE; NATURALLY OCCURRING REGULATORY T CELL; NEXT GENERATION SEQUENCING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ADOPTIVE TRANSFER; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DNA METHYLATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; SKIN;

ADOPTIVE TRANSFER; ANTIGENS, CD4; ANTIGENS, CD80; ANTIGENS, CD86; BASE SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CTLA-4 ANTIGEN; DENDRITIC CELLS; DNA METHYLATION; FORKHEAD TRANSCRIPTION FACTORS; HLA-DR ANTIGENS; HUMANS; IKAROS TRANSCRIPTION FACTOR; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-15; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; SEQUENCE ANALYSIS, RNA; SKIN; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929646227     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402827     Document Type: Article

References (70)

1. Maggi, E., L. Cosmi, F. Liotta, P. Romagnani, S. Romagnani, and F. Annunziato. 2005. Thymic regulatory T cells. Autoimmun. Rev. 4: 579-586.
2. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
3. Marek-Trzonkowska, N., M. Mysliwiec, A. Dobyszuk, M. Grabowska, I. Techmanska, J. Juscinska, M. A. Wujtewicz, P. Witkowski, W. Mlynarski, A. Balcerska, et al. 2012. Administration of CD4+CD25highCD127- regulatory T cells preserves b-cell function in type 1 diabetes in children. Diabetes Care 35: 1817-1820.
4. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
5. Tarbell, K. V., L. Petit, X. Zuo, P. Toy, X. Luo, A. Mqadmi, H. Yang, M. Suthanthiran, S. Mojsov, and R. M. Steinman. 2007. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204: 191-201.
6. Trzonkowski, P., M. Bieniaszewska, J. Jus̈cińska, A. Dobyszuk, A. Krzystyniak, N. Marek, J. Mys̈liwska, and A. Hellmann. 2009. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin. Immunol. 133: 22-26.
7. Brunstein, C. G., J. S. Miller, Q. Cao, D. H. McKenna, K. L. Hippen, J. Curtsinger, T. Defor, B. L. Levine, C. H. June, P. Rubinstein, et al. 2011. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117: 1061-1070.
8. Di Ianni, M., F. Falzetti, A. Carotti, A. Terenzi, F. Castellino, E. Bonifacio, B. Del Papa, T. Zei, R. I. Ostini, D. Cecchini, et al. 2011. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117: 3921-3928.
9. Sagoo, P., N. Ali, G. Garg, F. O. Nestle, R. I. Lechler, and G. Lombardi. 2011. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 3: 83ra42.
10. Putnam, A. L., N. Safinia, A. Medvec, M. Laszkowska, M. Wray, M. A. Mintz, E. Trotta, G. L. Szot, W. Liu, A. Lares, et al. 2013. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am. J. Transplant. 13: 3010-3020.
11. Litjens, N. H., K. Boer, and M. G. Betjes. 2012. Identification of circulating human antigen-reactive CD4+ FOXP3+ natural regulatory T cells. J. Immunol. 188: 1083-1090.
12. Hoffmann, P., T. J. Boeld, R. Eder, J. Albrecht, K. Doser, B. Piseshka, A. Dada, C. Niemand, M. Assenmacher, E. Orsó, et al. 2006. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol. Blood Marrow Transplant. 12: 267-274.
13. Wichlan, D. G., P. L. Roddam, P. Eldridge, R. Handgretinger, and J. M. Riberdy. 2006. Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity. J. Immunol. Methods 315: 27-36.
14. Earle, K. E., Q. Tang, X. Zhou, W. Liu, S. Zhu, M. L. Bonyhadi, and J. A. Bluestone. 2005. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 115: 3-9.
15. Hoffmann, P., R. Eder, and M. Edinger. 2011. Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells. Methods Mol. Biol. 677: 15-30.
16. Battaglia, M., A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M. G. Roncarolo. 2006. Rapamycin promotes expansion of functional CD4+ CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177: 8338-8347.
17. Battaglia, M., A. Stabilini, and M. G. Roncarolo. 2005. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748.
18. Peters, J. H., L. B. Hilbrands, H. J. Koenen, and I. Joosten. 2008. Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25 (high) T cells for immunotherapy. PLoS ONE 3: e2233.
19. Veerapathran, A., J. Pidala, F. Beato, X. Z. Yu, and C. Anasetti. 2011. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood 118: 5671-5680.
20. Chen, L. C., J. C. Delgado, P. E. Jensen, and X. Chen. 2009. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application. J. Immunol. 183: 4094-4102.
21. Brennan, T. V., Q. Tang, F. C. Liu, V. Hoang, M. Bi, J. A. Bluestone, and S. M. Kang. 2011. Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts. J. Surg. Res. 169: e69-e75.
22. Golshayan, D., S. Jiang, J. Tsang, M. I. Garin, C. Mottet, and R. I. Lechler. 2007. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 109: 827-835.
23. Joffre, O., T. Santolaria, D. Calise, T. Al Saati, D. Hudrisier, P. Romagnoli, and J. P. van Meerwijk. 2008. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14: 88-92.
24. Nadig, S. N., J. Wieckiewicz, D. C. Wu, G. Warnecke, W. Zhang, S. Luo, A. Schiopu, D. P. Taggart, and K. J. Wood. 2010. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med. 16: 809-813.
25. Trenado, A., F. Charlotte, S. Fisson, M. Yagello, D. Klatzmann, B. L. Salomon, and J. L. Cohen. 2003. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112: 1688-1696.
26. Tsang, J. Y., Y. Tanriver, S. Jiang, S. A. Xue, K. Ratnasothy, D. Chen, H. J. Stauss, R. P. Bucy, G. Lombardi, and R. Lechler. 2008. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J. Clin. Invest. 118: 3619-3628.
27. Yamazaki, S., T. Iyoda, K. Tarbell, K. Olson, K. Velinzon, K. Inaba, and R. M. Steinman. 2003. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198: 235-247.
28. Yamazaki, S., M. Patel, A. Harper, A. Bonito, H. Fukuyama, M. Pack, K. V. Tarbell, M. Talmor, J. V. Ravetch, K. Inaba, and R. M. Steinman. 2006. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. USA 103: 2758-2763.
29. Fehérvári, Z., and S. Sakaguchi. 2004. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16: 1769-1780.
30. Lutz, M. B. 2012. Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front. Immunol. 3: 123.
31. Xu, S., Z. Sun, Y. Sun, J. Zhu, X. Li, X. Zhang, G. Shan, Z. Wang, H. Liu, and X. Wu. 2011. IL-15 and dendritic cells induce proliferation of CD4+CD25+ regulatory T cells from peripheral blood. Immunol. Lett. 140: 59-67.
32. Litjens, N. H., J. van de Wetering, N. M. van Besouw, and M. G. Betjes. 2009. The human alloreactive CD4+ T-cell repertoire is biased to a Th17 response and the frequency is inversely related to the number of HLA class II mismatches. Blood 114: 3947-3955.
33. Litjens, N. H., M. Huisman, C. C. Baan, C. J. van Druningen, and M. G. Betjes. 2008. Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: limited usefulness of dendritic cells as signal enhancers. J. Immunol. Methods 330: 1-11.
34. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
35. de Gruijl, T. D., C. C. Sombroek, S. M. Lougheed, D. Oosterhoff, J. Buter, A. J. van den Eertwegh, R. J. Scheper, and H. M. Pinedo. 2006. A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. J. Immunol. 176: 7232-7242.
36. Game, D. S., M. P. Hernandez-Fuentes, and R. I. Lechler. 2005. Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am. J. Transplant. 5: 454-464.
37. Litjens, N. H., M. Huisman, D. Hijdra, B. M. Lambrecht, K. J. Stittelaar, and M. G. Betjes. 2008. IL-2 producing memory CD4+ T lymphocytes are closely associated with the generation of IgG-secreting plasma cells. J. Immunol. 181: 3665-3673.
38. Engela, A. U., M. J. Hoogduijn, K. Boer, N. H. Litjens, M. G. Betjes, W. Weimar, and C. C. Baan. 2013. Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. Clin. Exp. Immunol. 173: 343-354.
39. Dai, Z., C. J. Turtle, G. C. Booth, S. R. Riddell, T. A. Gooley, A. M. Stevens, T. Spies, and V. Groh. 2009. Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenileonset lupus. J. Exp. Med. 206: 793-805.
40. Kwekkeboom, J., D. de Rijk, A. Kasran, S. Barcy, C. de Groot, and M. de Boer. 1994. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40- CD40 ligand interaction. Eur. J. Immunol. 24: 508-517.
41. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10: 1593-1598.
42. Vermeiren, J., J. L. Ceuppens, H. Haegel-Kronenberger, M. De Boer, L. Boon, and S. W. Van Gool. 2004. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity. Clin. Exp. Immunol. 135: 253-258.
43. Wieczorek, G., A. Asemissen, F. Model, I. Turbachova, S. Floess, V. Liebenberg, U. Baron, D. Stauch, K. Kotsch, J. Pratschke, et al. 2009. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res. 69: 599-608.
44. Verkade, M. A., C. J. van Druningen, L. M. Vaessen, D. A. Hesselink, W. Weimar, and M. G. Betjes. 2007. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol. Dial. Transplant. 22: 128-138.
45. Hoffmann, P., R. Eder, L. A. Kunz-Schughart, R. Andreesen, and M. Edinger. 2004. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104: 895-903.
46. Granucci, F., C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2: 882-888.
47. Hoffmann, P., T. J. Boeld, R. Eder, J. Huehn, S. Floess, G. Wieczorek, S. Olek, W. Dietmaier, R. Andreesen, and M. Edinger. 2009. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 39: 1088-1097.
48. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
49. Zhou, X., S. Bailey-Bucktrout, L. T. Jeker, and J. A. Bluestone. 2009. Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 21: 281-285.
50. Tommasini, A., S. Ferrari, D. Moratto, R. Badolato, M. Boniotto, D. Pirulli, L. D. Notarangelo, and M. Andolina. 2002. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin. Exp. Immunol. 130: 127-130.
51. Himmel, M. E., K. G. MacDonald, R. V. Garcia, T. S. Steiner, and M. K. Levings. 2013. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J. Immunol. 190: 2001-2008.
52. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T. W. Mak, and S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192: 303-310.
53. Kingsley, C. I., M. Karim, A. R. Bushell, and K. J. Wood. 2002. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168: 1080-1086.
54. Pfoertner, S., A. Jeron, M. Probst-Kepper, C. A. Guzman, W. Hansen, A. M. Westendorf, T. Toepfer, A. J. Schrader, A. Franzke, J. Buer, and R. Geffers. 2006. Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol. 7: R54.
55. Birzele, F., T. Fauti, H. Stahl, M. C. Lenter, E. Simon, D. Knebel, A. Weith, T. Hildebrandt, and D. Mennerich. 2011. Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human. Nucleic Acids Res. 39: 7946-7960.
56. Sadlon, T. J., B. G. Wilkinson, S. Pederson, C. Y. Brown, S. Bresatz, T. Gargett, E. L. Melville, K. Peng, R. J. D'Andrea, G. G. Glonek, et al. 2010. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J. Immunol. 185: 1071-1081.
57. Liston, A., and C. A. Piccirillo. 2013. Developmental plasticity of murine and human Foxp3(+) regulatory T cells. Adv. Immunol. 119: 85-106.
58. Vang, K. B., J. Yang, S. A. Mahmud, M. A. Burchill, A. L. Vegoe, and M. A. Farrar. 2008. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181: 3285-3290.
59. Wuest, T. Y., J. Willette-Brown, S. K. Durum, and A. A. Hurwitz. 2008. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J. Leukoc. Biol. 84: 973-980.
60. Yates, J., F. Rovis, P. Mitchell, B. Afzali, J. Tsang, M. Garin, R. I. Lechler, G. Lombardi, and O. A. Garden. 2007. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 19: 785-799.
61. D'Cruz, L. M., and L. Klein. 2005. Development and function of agonistinduced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159.
62. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
63. Burchill, M. A., J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar. 2007. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178: 280-290.
64. Granucci, F., S. Feau, V. Angeli, F. Trottein, and P. Ricciardi-Castagnoli. 2003. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J. Immunol. 170: 5075-5081.
65. Feau, S., V. Facchinetti, F. Granucci, S. Citterio, D. Jarrossay, S. Seresini, M. P. Protti, A. Lanzavecchia, and P. Ricciardi-Castagnoli. 2005. Dendritic cellderived IL-2 production is regulated by IL-15 in humans and in mice. Blood 105: 697-702.
66. Sánchez-Fueyo, A., S. Sandner, A. Habicht, C. Mariat, J. Kenny, N. Degauque, X. X. Zheng, T. B. Strom, L. A. Turka, and M. H. Sayegh. 2006. Specificity of CD4+CD25+ regulatory T cell function in alloimmunity. J. Immunol. 176: 329-334.
67. Ding, Y., J. Xu, and J. S. Bromberg. 2012. Regulatory T cell migration during an immune response. Trends Immunol. 33: 174-180.
68. Pletinckx, K., A. Döhler, V. Pavlovic, and M. B. Lutz. 2011. Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front. Immunol. 2: 39.
69. Vukmanovic-Stejic, M., E. Agius, N. Booth, P. J. Dunne, K. E. Lacy, J. R. Reed, T. O. Sobande, S. Kissane, M. Salmon, M. H. Rustin, and A. N. Akbar. 2008. The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J. Clin. Invest. 118: 3639-3650.
70. Landwehr-Kenzel, S., F. Issa, S. H. Luu, M. Schmück, H. Lei, A. Zobel, A. Thiel, N. Babel, K. Wood, H. D. Volk, and P. Reinke. 2014. Novel GMPcompatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells. Am. J. Transplant. 14: 594-606.